SectorBiological Technology
Established Date01/03/2021
Listing Date26/05/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees39
Fiscal Year Ends31/12
Security TypeCommon stock
Office address2 Corporate Drive
First Floor
South San Francisco
CA 94080
Business
IntroductionSenti Biosciences, Inc., was incorporated in Delaware on March 1, 2021. The company is a clinical-stage biotechnology company that leverages its gene circuit platform technology to develop next-generation cell and gene therapies for patients with incurable diseases. The company's mission is to create a new generation of smarter medicines that use novel and unprecedented methods to defeat complex diseases.
